Northwestern Mutual Wealth Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$121K Buy
1,487
+34
+2% +$2.46K ﹤0.01% 2197
2026
Q1
$99K Hold
1,453
﹤0.01% 2179
2025
Q4
$110K Sell
1,453
-4
-0.3% -$291 ﹤0.01% 2096
2025
Q3
$89.4K Buy
1,457
+4
+0.3% +$208 ﹤0.01% 2086
2025
Q2
$71K Hold
1,453
﹤0.01% 2127
2025
Q1
$74K Hold
1,453
﹤0.01% 2043
2024
Q4
$65.6K Hold
1,453
﹤0.01% 2079
2024
Q3
$53.9K Hold
1,453
﹤0.01% 2126
2024
Q2
$44.4K Hold
1,453
﹤0.01% 2128
2024
Q1
$42.3K Hold
1,453
﹤0.01% 2148
2023
Q4
$40K Hold
1,453
﹤0.01% 2133
2023
Q3
$32.6K Sell
1,453
-27
-2% -$1K ﹤0.01% 2131
2023
Q2
$60.2K Buy
1,480
+27
+2% +$1.32K ﹤0.01% 1916
2023
Q1
$70.4K Hold
1,453
﹤0.01% 1815
2022
Q4
$55.5K Hold
1,453
﹤0.01% 1878
2022
Q3
$73K Hold
1,453
﹤0.01% 1755
2022
Q2
$58K Hold
1,453
﹤0.01% 1866
2022
Q1
$54K Hold
1,453
﹤0.01% 1929
2021
Q4
$58K Hold
1,453
﹤0.01% 1929
2021
Q3
$54K Hold
1,453
﹤0.01% 1873
2021
Q2
$61K Hold
1,453
﹤0.01% 1784
2021
Q1
$69K Hold
1,453
﹤0.01% 1620
2020
Q4
$89K Buy
+1,453
New +$85.6K ﹤0.01% 1440
2016
Q4
Sell
-40
Closed -$1K 2478
2016
Q3
$1K Hold
40
﹤0.01% 2077
2016
Q2
$0 Buy
+40
New +$293 ﹤0.01% 2218

Other funds holding PTCT

Northwestern Mutual Wealth Management's PTCT Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its PTC Therapeutics (PTCT) stake by 2.3% in Q2 2026, buying an estimated $2.46K and bringing the position to 1,487 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #2197.

Northwestern Mutual Wealth Management first reported a position in PTCT in Q2 2016 and has held it in 25 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Northwestern Mutual Wealth Management held 1,487 shares of PTC Therapeutics worth $121K as of Q2 2026.
  • Northwestern Mutual Wealth Management bought 34 PTC Therapeutics shares in Q2 2026, an estimated $2.46K.
  • PTC Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2197 holding.
  • Northwestern Mutual Wealth Management first reported a position in PTC Therapeutics in Q2 2016 and has held it in 25 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.